Free Trial

Bruker (BRKR) Competitors

$66.81
+2.58 (+4.02%)
(As of 07/26/2024 ET)

BRKR vs. PKI, AVTR, TXG, QTRX, MTD, ILMN, WAT, TECH, CRL, and BIO

Should you be buying Bruker stock or one of its competitors? The main competitors of Bruker include Revvity (PKI), Avantor (AVTR), 10x Genomics (TXG), Quanterix (QTRX), Mettler-Toledo International (MTD), Illumina (ILMN), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), and Bio-Rad Laboratories (BIO).

Bruker vs.

Bruker (NASDAQ:BRKR) and Revvity (NYSE:PKI) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, community ranking, media sentiment, analyst recommendations, dividends and profitability.

Revvity has a net margin of 28.94% compared to Bruker's net margin of 13.38%. Bruker's return on equity of 27.31% beat Revvity's return on equity.

Company Net Margins Return on Equity Return on Assets
Bruker13.38% 27.31% 8.82%
Revvity 28.94%11.17%5.83%

Bruker currently has a consensus price target of $81.78, indicating a potential upside of 22.40%. Revvity has a consensus price target of $54.00, indicating a potential upside of ∞. Given Revvity's stronger consensus rating and higher possible upside, analysts clearly believe Revvity is more favorable than Bruker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bruker
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.56
Revvity
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Bruker had 10 more articles in the media than Revvity. MarketBeat recorded 10 mentions for Bruker and 0 mentions for Revvity. Revvity's average media sentiment score of 0.73 beat Bruker's score of 0.56 indicating that Revvity is being referred to more favorably in the news media.

Company Overall Sentiment
Bruker Positive
Revvity Positive

Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.3%. Revvity pays an annual dividend of $0.28 per share. Bruker pays out 7.3% of its earnings in the form of a dividend. Revvity pays out 3.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Bruker has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Revvity has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500.

79.5% of Bruker shares are owned by institutional investors. Comparatively, 85.2% of Revvity shares are owned by institutional investors. 28.3% of Bruker shares are owned by company insiders. Comparatively, 0.5% of Revvity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Bruker received 169 more outperform votes than Revvity when rated by MarketBeat users. Likewise, 64.83% of users gave Bruker an outperform vote while only 59.74% of users gave Revvity an outperform vote.

CompanyUnderperformOutperform
BrukerOutperform Votes
669
64.83%
Underperform Votes
363
35.17%
RevvityOutperform Votes
500
59.74%
Underperform Votes
337
40.26%

Revvity has higher revenue and earnings than Bruker. Revvity is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bruker$2.96B3.28$427.20M$2.7524.29
Revvity$3.31B0.00$569.18M$7.68N/A

Summary

Bruker beats Revvity on 10 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BRKR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BRKR vs. The Competition

MetricBrukerAnalytical instruments IndustryComputer SectorNASDAQ Exchange
Market Cap$9.71B$5.34B$22.17B$8.19B
Dividend Yield0.31%0.42%2.70%3.96%
P/E Ratio24.2932.16266.5618.37
Price / Sales3.285.64610.0188.82
Price / Cash17.9342.1431.7134.13
Price / Book6.633.356.894.51
Net Income$427.20M-$396,363.64$637.08M$216.36M
7 Day Performance7.95%7.57%0.70%1.82%
1 Month Performance4.07%8.76%3.58%7.09%
1 Year Performance-4.38%-30.15%12.57%4.88%

Bruker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PKI
Revvity
4.3536 of 5 stars
4.35 / 5 stars
N/A$54.00
+∞
N/A$14.57B$3.31B15.0116,700Analyst Forecast
AVTR
Avantor
4.2901 of 5 stars
4.29 / 5 stars
$22.52
+6.4%
$25.93
+15.1%
+9.6%$15.30B$6.87B57.7414,500Options Volume
News Coverage
Gap Up
High Trading Volume
TXG
10x Genomics
4.6319 of 5 stars
4.63 / 5 stars
$18.85
-0.6%
$36.29
+92.5%
-66.7%$2.25B$618.73M-8.451,259Analyst Forecast
QTRX
Quanterix
1.2949 of 5 stars
1.29 / 5 stars
$15.16
-0.5%
$28.60
+88.7%
-33.7%$580.17M$122.37M-15.79460Gap Up
MTD
Mettler-Toledo International
4.3329 of 5 stars
4.33 / 5 stars
$1,385.78
+1.8%
$1,301.25
-6.1%
+8.6%$29.60B$3.79B38.8617,300Upcoming Earnings
Short Interest ↓
Analyst Revision
News Coverage
ILMN
Illumina
4.8679 of 5 stars
4.87 / 5 stars
$115.70
+0.1%
$158.57
+37.1%
-37.0%$18.43B$4.49B-14.209,300Positive News
WAT
Waters
4.3907 of 5 stars
4.39 / 5 stars
$303.87
+1.0%
$301.20
-0.9%
+9.7%$18.03B$2.96B29.827,900Upcoming Earnings
News Coverage
TECH
Bio-Techne
4.5892 of 5 stars
4.59 / 5 stars
$77.35
+1.1%
$81.00
+4.7%
-5.2%$12.19B$1.14B61.393,050Short Interest ↓
CRL
Charles River Laboratories International
4.5188 of 5 stars
4.52 / 5 stars
$221.74
+0.7%
$252.29
+13.8%
+9.6%$11.42B$4.13B26.0921,800News Coverage
Positive News
BIO
Bio-Rad Laboratories
4.3557 of 5 stars
4.36 / 5 stars
$308.74
+1.2%
$436.67
+41.4%
-24.4%$8.81B$2.67B-29.808,030Upcoming Earnings
Short Interest ↑
News Coverage

Related Companies and Tools

This page (NASDAQ:BRKR) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners